Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
The Journal of Dermatological Treatment|November 8, 2018
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritisOmbretta Viapiana, Elena FracassiBone Research|August 15, 2015
Osteoporosis Treatment: When to Discontinue and When to Re-startSilvano Adami, Luca Idolazzi, Elena Fracassi, et al.Expert Opinion on Drug Metabolism & Toxicology|September 19, 2009
Neridronic acid for the treatment of bone metabolic diseasesDavide Gatti, Ombretta Viapiana, Luca Idolazzi, et al.Rheumatology International|November 2, 2015
Focal bone involvement in inflammatory arthritis: the role of IL17Maurizio Rossini, Ombretta Viapiana, Silvano Adami, et al.Bone|December 20, 2011
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostinDavide Gatti, Ombretta Viapiana, Silvano Adami, et al.The Journal of Clinical Endocrinology and Metabolism|March 4, 2011
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1Davide Gatti, Ombretta Viapiana, Luca Idolazzi, et al.SAGE Open Medical Case Reports|July 8, 2025
A successful combination of upadacitinib and guselkumab in refractory psoriasis and psoriatic arthritis: A case reportSofia Antolini, Giorgia Scagliosi, Olta Veliaj, et al.Rheumatology International|August 24, 2014
Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatmentOmbretta Viapiana, Davide Gatti, Sonila Troplini, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 30, 2011
Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administrationMaurizio Rossini, Silvano Adami, Ombretta Viapiana, et al.Calcified Tissue International|February 23, 2013
Sclerostin and DKK1 in primary hyperparathyroidismOmbretta Viapiana, Elena Fracassi, Sonila Troplini, et al.Pageof 6